|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 100, 353-357, Copyright © 1990 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
DM Gartman, GH Bardy, MD Allen, GA Misbach and TD Ivey
Over the 3-year period from Jan. 1, 1986, through Dec. 31, 1988, we have
implanted 101 automatic implantable cardioverter-defibrillators into
patients with life-threatening ventricular arrhythmias. There were 82 male
patients and 19 female patients. The mean age was 58 years with a range of
25 to 82 years. The indication for implantation was ventricular
fibrillation in 89 patients and recurrent ventricular tachycardia in 12
patients. Seventy-seven patients had a history of prior myocardial
infarction or coronary artery disease, or both. Eighteen patients had
nonischemic cardiomyopathy. One patient had a prolonged QT syndrome and
five patients had no evidence of preexisting structural heart disease. The
mean injection fraction was 37% +/- 17%. Forty-one of the automatic
implantable cardioverter-defibrillator implantations were associated with
procedures necessitating cardiopulmonary bypass. The hospital mortality
rate was 4% and the morbidity rate was 15%. The only statistical difference
between those patients who did and did not have postoperative complications
was a history of a prior myocardial infarction (90% versus 54%, p less than
0.05). Twenty percent of patients had new-onset postoperative atrial
fibrillation after implantation of the device. Eleven percent of patients
had sustained ventricular tachycardia postoperatively. Although there was a
trend toward a higher complication/death rate in the patients whose
automatic implantable cardioverter-defibrillator was inserted in
association with cardiopulmonary bypass (24% versus 15%) and the occurrence
of new-onset postoperative atrial fibrillation (27% versus 15%), these
findings were not statistically significant. Automatic implantable
cardioverter-defibrillator implantation with and without concomitant
cardiopulmonary bypass is associated with a clinically important morbidity
and mortality rate and development of postoperative arrhythmias.
ARTICLES
Short-term morbidity and mortality of implantation of automatic implantable cardioverter-defibrillator
Department of Surgery, University of Washington, Seattle 98195.
This article has been cited by other articles:
![]() |
C. R. Cartwright and L. L. Hill Anesthesia for Insertion of Implantable Cardioverter Defibdilators Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2000; 4(3): 180 - 186. [Abstract] [PDF] |
||||
![]() |
S. L. Pinski and G. J. Fahy The Proarrhythmic Potential of Implantable Cardioverter-Defibrillators Circulation, September 15, 1995; 92(6): 1651 - 1664. [Abstract] [Full Text] |
||||
![]() |
D. M. Shahian, W. A. Williamson, L. G. Svensson, R. S. D'Agostino, D. T. Martin, J. R. Ellis, and F. J. Venditti Transvenous versus transthoracic cardioverter-defibrillator implantation: A comparative analysis of morbidity, mortality, and survival J. Thorac. Cardiovasc. Surg., June 1, 1995; 109(6): 1066 - 1074. [Abstract] [Full Text] |
||||
![]() |
J. M. Piehler, D. A. Killen, A. M. Borkon, W. A. Reed, M. E. Gorton, G. M. Gura Jr, and A. H. Kragel Right Atrial Compression Related to Defibrillator Patches Ann. Thorac. Surg., March 1, 1995; 59(3): 684 - 688. [Abstract] [Full Text] |
||||
![]() |
R. Lee, J. D. Mitchell, H. Garan, J. N. Ruskin, B. A. McGovern, M. J. Buckley, D. F. Torchiana, and G. J. Vlahakes Operation for recurrent ventricular tachycardiaPredictors of short- and long-term efficacy J. Thorac. Cardiovasc. Surg., March 1, 1994; 107(3): 732 - 742. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |